DNLI · Denali Therapeutics Inc.
$24.40
-0.42 (-1.69%)
At close · Aug 14
Market Cap
$3.90B
Shares
159.85M
Denali Therapeutics Inc. Earnings Call Transcripts
Every quarterly earnings call for Denali Therapeutics Inc. (DNLI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q2
2026-08-06
Denali Therapeutics Inc. Q2 FY2026 Earnings Call
Confident tone
Ablea commercial launch
Patient and physician engagement
Transport vehicle platform
Revenue
$3.60M
Diluted EPS
$-0.68
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Goldman Sachs Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference in New York
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-25
Denali Therapeutics Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Denali Therapeutics Inc. Q3 FY2025 Earnings Call
Confident tone
Blood-brain barrier / Transport Vehicle platform
Sanfilippo enzyme replacement therapy program
Alzheimer's disease programs (tau and A-beta)
Diluted EPS
$-0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
Denali Therapeutics Inc. Q3 FY2020 Earnings Call
Revenue
$9.39M
▼ 31% YoY Diluted EPS
$-0.54
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts
CIK
1714899
CUSIP
24823R105
13F (30d)
277 filings
272 filers
Visit website
Investor relations